Download PDF
Homeopathy 2021; 110(03): 174-179
DOI: 10.1055/s-0040-1722234
Original Research Article

In Vitro Assessment of Cytoprotective Effects of CANOVA against Cell Death Induced by the Anti-malarial Artesunate – A Preliminary Experiment

Laís Teixeira Bonfim 
1   Laboratory of Human Cytogenetic, Institute of Biological Sciences, Federal University of Pará (UFPA), Belém, Pará, Brazil
,
Marcelo de Oliveira Bahia 
1   Laboratory of Human Cytogenetic, Institute of Biological Sciences, Federal University of Pará (UFPA), Belém, Pará, Brazil
› Author Affiliations Funding This work was supported by the Paraense Amazon Foundation for Research Support, FAPESPA.
› Further Information
    Permissions and Reprints

Abstract

Background Artesunate (ATS) is a semi-synthetic compound derived from artemisinin, which is widely accepted in the treatment of malaria. However, there is evidence that ATS, under certain in vitro conditions, induces several impairments to normal cell functions. Canova (CA) is a Brazilian homeopathic formulation indicated for patients with depressed immune system. CA shows both in vitro and in vivo protective effects against mutagenic/carcinogenic compounds. Therefore, we aimed to assess in vitro the cytoprotective effects of CA against the cytotoxicity of ATS in Vero cells.

Methods Viability of Vero cells exposed to ATS was assessed by MTT assay, whereas the anti-cytotoxic effect of CA was evaluated by apoptosis and necrosis quantification with fluorescent dyes.

Results After 24 hours of ATS treatment, a reduction in cell viability was observed at 32 and 64 µg/mL, the latter being statistically significant (p < 0.05) in relation to the negative control. The concentration of 64 µg/mL was chosen for the subsequent experiments. ATS significantly induced both apoptosis and necrosis in Vero cells in relation to controls (p < 0.01). We also observed a statistically significant decrease in the number of apoptotic cells observed in the CA 16% + ATS co-treatment compared with ATS treatment (p < 0.01). Treatment with CA alone also had no influence on either type of cell death.

Conclusion Our results demonstrated that ATS is cytotoxic in the assessed conditions. However, such cytotoxicity was attenuated when the cells were treated simultaneously with ATS and CA.

Keywords

artesunate - Canova - cytoprotection - necrosis - apoptosis


Publication History

Received: 13 August 2020

Accepted: 30 September 2020

Article published online:
04 March 2021

© 2021. Faculty of Homeopathy. This article is published by Thieme.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 

  • References

  • 1 Kouakou YI, Tod M, Leboucher G. et al. Systematic review of artesunate pharmacokinetics: implication for treatment of resistant malaria. Int J Infect Dis 2019; 89: 30-44
    CrossrefPubMedGoogle Scholar
  • 2 Zuo W, Wang ZZ, Xue J. Artesunate induces apoptosis of bladder cancer cells by miR-16 regulation of COX-2 expression. Int J Mol Sci 2014; 15: 14298-14312
    CrossrefPubMedGoogle Scholar
  • 3 Yang ND, Tan SH, Ng S. et al. Artesunate induces cell death in human cancer cells via enhancing lysosomal function and lysosomal degradation of ferritin. J Biol Chem 2014; 289: 33425-33441
    CrossrefPubMedGoogle Scholar
  • 4 Mota TC, Cardoso PC, Gomes LM. et al. In vitro evaluation of the genotoxic and cytotoxic effects of artesunate, an antimalarial drug, in human lymphocytes. Environ Mol Mutagen 2011; 52: 590-594
    CrossrefPubMedGoogle Scholar
  • 5 Mota TC, Garcia TB, Bonfim LT. et al. Markers of oxidative-nitrosative stress induced by artesunate are followed by clastogenic and aneugenic effects and apoptosis in human lymphocytes. J Appl Toxicol 2019; 39: 1405-1412
    CrossrefPubMedGoogle Scholar
  • 6 Cesar B, Abud AP, de Oliveira CC. et al. Activation of mononuclear bone marrow cells treated in vitro with a complex homeopathic medication. Micron 2008; 39: 461-470
    CrossrefPubMedGoogle Scholar
  • 7 Di Bernardi L. Recovery of HIV/AIDS patients in Botswana, Africa, using the homeopathic medicine Canova [Master Dissertation]. Federal University of Paraná. 2006
    PubMedGoogle Scholar
  • 8 de Oliveira CC, de Oliveira SM, Godoy LMF, Gabardo J, Buchi DdeF. Canova, a Brazilian medical formulation, alters oxidative metabolism of mice macrophages. J Infect 2006; 52: 420-432
    CrossrefPubMedGoogle Scholar
  • 9 Sato DY, Wal R, de Oliveira CC. et al. Histopathological and immunophenotyping studies on normal and sarcoma 180-bearing mice treated with a complex homeopathic medication. Homeopathy 2005; 94: 26-32
    Article in Thieme ConnectPubMedGoogle Scholar
  • 10 Pereira WKV, Lonardoni MVC, Grespan R, Caparroz-Assef SM, Cuman RKN, Bersani-Amado CA. Immunomodulatory Effect of Canova Medication on Experimental Leishmania Amazonensis Infection. The British Infection Society. Elsevier Ltd; 2004: 09.009
    Google Scholar
  • 11 Nascimento HFS, Cardoso PCDS, Ribeiro HF. et al. In vitro assessment of anticytotoxic and antigenotoxic effects of CANOVA(®). Homeopathy 2016; 105: 265-269
    Article in Thieme ConnectPubMedGoogle Scholar
  • 12 Leal MF, Antunes LMG, Lamarão MFV. et al. The protective effect of Canova homeopathic medicine in cyclophosphamide-treated non-human primates. Food Chem Toxicol 2012; 50: 4412-4420
    CrossrefPubMedGoogle Scholar
  • 13 Yasumura Y. The research for the SV40 by means of tissue culture technique. Nihon rinsho. Nihon Rinsho 1963; 21: 1201-1215
    PubMedGoogle Scholar
  • 14 ANVISA, Agência Nacional de Vigilância Sanitária, Formulário homeopático. Farmacopeia brasileira. 2nd ed.. Brasília-DF: 2019. . Accessed September 09, 2020 at: http://portal.anvisa.gov.br/documents/33832/3653739/Formul%C3%A1rio+Homeop%C3%A1tico%2C+2%C2%AA+edi%C3%A7%C3%A3o.pdf/81cf5ba6-7255-4c78-96e9-846bb0d447e5
    Google Scholar
  • 15 Hashimoto Y, Shimada Y, Itami A. et al. Growth inhibition through activation of peroxisome proliferator-activated receptor γ in human oesophageal squamous cell carcinoma. Eur J Cancer 2003; 39: 2239-2246
    CrossrefPubMedGoogle Scholar
  • 16 Ayres M, Ayres MJ, Ayres DM, Dos Santos AS. Bioestat 5.0: Statistical Applications in the Biological and Medical Sciences. Belém, PA: ONG Mamiraua; 2007
    Google Scholar
  • 17 Feio DCA, Muniz JAPC, Montenegro RC, Burbano RR, De Brito Junior LC, De Lima PD. Evaluation of the immunological cellular response of Cebus apella exposed to the carcinogen N-methyl-N-nitrosourea and treated with CANOVA®. In Vivo 2014; 28: 837-841
    PubMedGoogle Scholar
  • 18 Zhou Z, Feng Y. Artesunate reduces proliferation, interferes DNA replication and cell cycle and enhances apoptosis in vascular smooth muscle cells. J Huazhong Univ Sci Technolog Med Sci 2005; 25: 135-136 , 177
    CrossrefPubMedGoogle Scholar
  • 19 Chen HH, Zhou HJ, Fang X. Inhibition of human cancer cell line growth and human umbilical vein endothelial cell angiogenesis by artemisinin derivatives in vitro. Pharmacol Res 2003; 48: 231-236
    CrossrefPubMedGoogle Scholar
  • 20 da Costa JdeF, Leal MF, Silva TC. et al. Experimental gastric carcinogenesis in Cebus apella nonhuman primates. PLoS One 2011; 6: e21988
    CrossrefPubMedGoogle Scholar
  • 21 de Oliveira CC, de Oliveira SM, Goes VM, Probst CM, Krieger MA, Buchi DdeF. Gene expression profiling of macrophages following mice treatment with an immunomodulator medication. J Cell Biochem 2008; 104: 1364-1377
    CrossrefPubMedGoogle Scholar
  • 22 Cheng R, Li C, Li C. et al. The artemisinin derivative artesunate inhibits corneal neovascularization by inducing ROS-dependent apoptosis in vascular endothelial cells. Invest Ophthalmol Vis Sci 2013; 54: 3400-3409
    CrossrefPubMedGoogle Scholar
  • 23 Cho HJ, Park SM, Hwang EM. et al. Gadd45b mediates Fas-induced apoptosis by enhancing the interaction between p38 and retinoblastoma tumor suppressor. J Biol Chem 2010; 285: 25500-25505
    CrossrefPubMedGoogle Scholar
  • 24 Zazzeroni F, Papa S, Algeciras-Schimnich A. et al. Gadd45 beta mediates the protective effects of CD40 costimulation against Fas-induced apoptosis. Blood 2003; 102: 3270-3279
    CrossrefPubMedGoogle Scholar